Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy.
Pasqualucci D, Fornaro A, Castelli G, Rossi A, Arretini A, Chiriatti C, Targetti M, Girolami F, Corda M, Orrù P, Matta G, Stefàno P, Cecchi F, Porcu M, Olivotto I. Pasqualucci D, et al. Among authors: arretini a. Circ Heart Fail. 2015 Nov;8(6):1014-21. doi: 10.1161/CIRCHEARTFAILURE.114.001843. Epub 2015 Oct 7. Circ Heart Fail. 2015. PMID: 26446673
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events.
Maurizi N, Passantino S, Spaziani G, Girolami F, Arretini A, Targetti M, Pollini I, Tomberli A, Pradella S, Calabri GB, Vinattieri V, Bertaccini B, Leone O, De Simone L, Rapezzi C, Marchionni N, Cecchi F, Favilli S, Olivotto I. Maurizi N, et al. Among authors: arretini a. JAMA Cardiol. 2018 Jun 1;3(6):520-525. doi: 10.1001/jamacardio.2018.0789. JAMA Cardiol. 2018. PMID: 29710196 Free PMC article.
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.
Cavigli L, Fumagalli C, Maurizi N, Rossi A, Arretini A, Targetti M, Passantino S, Girolami F, Tomberli B, Baldini K, Tomberli A, Antoniucci D, Yacoub MH, Marchionni N, Stefano PL, Cecchi F, Olivotto I. Cavigli L, et al. Among authors: arretini a. Int J Cardiol. 2018 Dec 15;273:155-161. doi: 10.1016/j.ijcard.2018.09.004. Epub 2018 Sep 5. Int J Cardiol. 2018. PMID: 30213605
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy.
Ghiselli L, Marchi A, Fumagalli C, Maurizi N, Oddo A, Pieri F, Girolami F, Rowin E, Mazzarotto F, Cicoira M, Ribichini F, Arretini A, Targetti M, Passantino S, Cecchi F, Marchionni N, Maron M, Mori F, Olivotto I. Ghiselli L, et al. Among authors: arretini a. Eur J Prev Cardiol. 2020 Nov;27(17):1821-1831. doi: 10.1177/2047487319886961. Epub 2019 Nov 7. Eur J Prev Cardiol. 2020. PMID: 31698967
Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long-term results and clinical outcomes.
Castagno D, Di Donna P, Olivotto I, Frontera A, Calò L, Scaglione M, Arretini A, Anselmino M, Giustetto C, De Ferrari GM, Cecchi F, Haissaguerre M, Gaita F. Castagno D, et al. Among authors: arretini a. J Cardiovasc Electrophysiol. 2021 Mar;32(3):657-666. doi: 10.1111/jce.14880. Epub 2021 Jan 24. J Cardiovasc Electrophysiol. 2021. PMID: 33428271 Free article.
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry.
Lopes LR, Losi MA, Sheikh N, Laroche C, Charron P, Gimeno J, Kaski JP, Maggioni AP, Tavazzi L, Arbustini E, Brito D, Celutkiene J, Hagege A, Linhart A, Mogensen J, Garcia-Pinilla JM, Ripoll-Vera T, Seggewiss H, Villacorta E, Caforio A, Elliott PM; Cardiomyopathy Registry Investigators Group. Lopes LR, et al. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):42-53. doi: 10.1093/ehjqcco/qcac006. Eur Heart J Qual Care Clin Outcomes. 2022. PMID: 35138368 Free PMC article.